BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia.
Yafeng ZhouJianbiao ZhouXiao LuTuan-Zea TanWee-Joo ChngPublished in: BMC cancer (2018)
These findings provide novel insight on how BET inhibitor can induce apoptosis in AML, and further support the development of BET inhibitors as a promising therapeutic strategy against AML.